Prevalence figures for inherited neuromuscular disorders are important
both for health care planning purposes and for evaluating the need fo
r DNA diagnostic services for eugenic approaches. We screened for the
prevalence of myotonic dystrophy (MyD) through extensive inquiry of ne
urologic and primary health services of Guipuzcoa (Basque Country, nor
thern Spain) between 1989 and 1991. Typical adult-onset and neonatal c
ases and relatives at risk, suffering from a partial syndrome, were in
cluded. In the latter, molecular typing was performed with DNA probes
close to the MyD gene to demonstrate the MyD gene carrier status. The
high prevalence detected (26.5 cases per 100,000 population) could be
explained by methodological factors, but intrinsic factors, such as a
possible founder genetic effect or the quick growth of the Guipuzcoa p
opulation since the last century may contribute to one of the highest
MyD prevalences in the world. In the future, the methodological basis
for epidemiologic surveys of MyD must combine molecular technology wit
h more-extensive family inquiries.